Publicaciones

• The Lancet Neurology
  Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with Down’s syndrome TESDAD: a double-blind, randomised, placebo-controlled, phase 2 trial

e-mail: cridard@imim.es :: 2012-2016© cridard.imim.es :: Leer Aviso Legal y Política de Privacidad.